Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. 2020

Peter Richardson, and Ivan Griffin, and Catherine Tucker, and Dan Smith, and Olly Oechsle, and Anne Phelan, and Michael Rawling, and Edward Savory, and Justin Stebbing
BenevolentAI, London, UK.

UI MeSH Term Description Entries
D011024 Pneumonia, Viral Inflammation of the lung parenchyma that is caused by a viral infection. Pneumonias, Viral,Viral Pneumonia,Viral Pneumonias
D011687 Purines A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000073640 Betacoronavirus A genus of the family CORONAVIRIDAE which causes respiratory or gastrointestinal disease in a variety of mostly mammals. Human betacoronaviruses include HUMAN ENTERIC CORONAVIRUS; HUMAN CORONAVIRUS OC43; MERS VIRUS; and SEVERE ACUTE RESPIRATORY SYNDROME-RELATED CORONAVIRUS. Members have either core transcription regulatory sequences of 5’-CUAAAC-3’ or 5’-CUAAAC-3’ and mostly have no ORF downstream to the N protein gene. HCoV-HKU1,Human coronavirus HKU1,Pipistrellus bat coronavirus HKU5,Rousettus bat coronavirus HKU9,Tylonycteris bat coronavirus HKU4,Betacoronaviruses
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D000093485 COVID-19 Drug Treatment The use of DRUGS to treat COVID19 or its symptoms. COVID-19 Drug Therapy,COVID19 Drug Therapy,COVID19 Drug Treatment,Coronavirus Disease 2019 Drug Treatment,Coronavirus Disease-19 Drug Treatment,COVID 19 Drug Therapy,COVID 19 Drug Treatment,COVID-19 Drug Therapies,COVID19 Drug Therapies,COVID19 Drug Treatments,Coronavirus Disease 19 Drug Treatment,Drug Therapy, COVID-19,Drug Therapy, COVID19,Therapy, COVID-19 Drug,Therapy, COVID19 Drug,Treatment, COVID-19 Drug
D001384 Azetidines
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide

Related Publications

Peter Richardson, and Ivan Griffin, and Catherine Tucker, and Dan Smith, and Olly Oechsle, and Anne Phelan, and Michael Rawling, and Edward Savory, and Justin Stebbing
November 2020, European journal of medicinal chemistry,
Peter Richardson, and Ivan Griffin, and Catherine Tucker, and Dan Smith, and Olly Oechsle, and Anne Phelan, and Michael Rawling, and Edward Savory, and Justin Stebbing
March 2020, The Lancet. Infectious diseases,
Peter Richardson, and Ivan Griffin, and Catherine Tucker, and Dan Smith, and Olly Oechsle, and Anne Phelan, and Michael Rawling, and Edward Savory, and Justin Stebbing
March 2020, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases,
Peter Richardson, and Ivan Griffin, and Catherine Tucker, and Dan Smith, and Olly Oechsle, and Anne Phelan, and Michael Rawling, and Edward Savory, and Justin Stebbing
February 2020, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases,
Peter Richardson, and Ivan Griffin, and Catherine Tucker, and Dan Smith, and Olly Oechsle, and Anne Phelan, and Michael Rawling, and Edward Savory, and Justin Stebbing
February 2020, Lancet (London, England),
Peter Richardson, and Ivan Griffin, and Catherine Tucker, and Dan Smith, and Olly Oechsle, and Anne Phelan, and Michael Rawling, and Edward Savory, and Justin Stebbing
January 2021, Current drug discovery technologies,
Peter Richardson, and Ivan Griffin, and Catherine Tucker, and Dan Smith, and Olly Oechsle, and Anne Phelan, and Michael Rawling, and Edward Savory, and Justin Stebbing
December 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Peter Richardson, and Ivan Griffin, and Catherine Tucker, and Dan Smith, and Olly Oechsle, and Anne Phelan, and Michael Rawling, and Edward Savory, and Justin Stebbing
January 2020, Travel medicine and infectious disease,
Peter Richardson, and Ivan Griffin, and Catherine Tucker, and Dan Smith, and Olly Oechsle, and Anne Phelan, and Michael Rawling, and Edward Savory, and Justin Stebbing
February 2020, Communicable diseases intelligence (2018),
Peter Richardson, and Ivan Griffin, and Catherine Tucker, and Dan Smith, and Olly Oechsle, and Anne Phelan, and Michael Rawling, and Edward Savory, and Justin Stebbing
March 2021, Journal of molecular structure,
Copied contents to your clipboard!